The antibiotic-resistant infection treatment market is estimated to grow substantially in the coming years. Antibiotic resistance occurs when microorganisms become adapted to a drug and stop reacting to medications that earlier easily treated an infection. The infection becomes hard to treat, resulting in increased deaths. Among other causes, worldwide antimicrobial resistance accounts for nearly 5 million deaths yearly, with 25.7% directly attributed to bacterial antimicrobial resistance. Significant research and development investment in the pharmaceutical and other therapeutic sectors is spurring market growth.
Other factors also contribute to market growth, including a growing prevalence of antibiotic-resistant pathogens that cause several infectious and neurological conditions, making patients more susceptible to infections. In general, these patients require prolonged or repeated courses of antibiotics, which enhance the risk of resistance. Personalized medicine, which tailors antibiotic therapy according to an individual patient's historical status, offers hope in curbing resistance. The antibiotic-resistant infection treatment market is expected to grow in the coming years due to demand in countries like the United States, China, and India.
Download
Actionable Solutions
